Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

267.06 -4.89 (-1.80%)
Streaming Delayed Price Updated: 1:38 PM EDT, Sep 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
Top dow jones movers in Monday's session ↗
Via Chartmill
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
AbbVie bets on pipeline diversification amid patent cliffs, while J&J's higher profitability masks litigation risks, a choice between growth ambition and defensive stability. 
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property
Johnson & Johnson (NYSE:JNJ): A Dividend Quality Pick for Income Investors ↗
Via Chartmill
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
Stay informed with the top movers within the dow jones index on Thursday. ↗
Via Chartmill
Thursday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
Bear Markets May Feel Frightening, But Here's How You Can Come Out Ahead ↗
The next bear market may be your best opportunity to grow your portfolio. 
Via The Motley Fool
Topics Economy
News headline image
Bristol Myers Squibb and Johnson & Johnson Both Face Challenges Ahead: Which Healthcare Stock Looks More Resilient Now? ↗
Bristol Myers Squibb trades at a steep valuation discount, while Johnson & Johnson's stronger margins and lower debt offer stability. But patent cliffs and litigation risks complicate both cases. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Intuitive Surgical Stock Has Plunged 29% This Year. Is the Market Overreacting? ↗
Wall Street thinks that this robotic surgical systems leader's sell-off is overdone. 
Via The Motley Fool
Topics Earnings
News headline image
2 Stocks to Buy Hand Over Fist if a Stock Market Crash Is Coming ↗
You can take these companies' dividends straight to the bank. 
Via The Motley Fool
Topics Economy
News headline image
Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal ↗
Healthcare giant Johnson & Johnson is looking to become a more profitable and faster-growing business. 
Via The Motley Fool
News headline image
The Investing Playbook for Retirees Who Can't Afford to Lose ↗
It may not be possible to avoid all risks, but it's certainly possible to minimize them. 
Via The Motley Fool
Topics Economy Retirement
These dow jones stocks are moving in today's session ↗
Via Chartmill
Which dow jones stocks are moving on Friday? ↗
Via Chartmill
News headline image
Meet the Vanguard ETF That Increased Its SpaceX Holding by 39% in 1 Month and Shows No Signs of Slowing Down ↗
The unlocking of SpaceX shares is reshaping the communications sector. 
Via The Motley Fool
Topics ETFs
News headline image
Better Dividend King to Buy and Hold: Johnson & Johnson or Kenvue? ↗
One healthcare dividend payer carries legal risk, the other faces a buyout. Here's which one actually deserves your money. 
Via The Motley Fool
News headline image
Johnson & Johnson Sees Path to Double-Digit Growth Despite 2026 Patent Cliff ↗
Johnson & Johnson (NYSE:JNJ) Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously stated 5% to 7% long-term range, supported by its... 
Via MarketBeat
Topics Intellectual Property
News headline image
The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks ↗
As Fed and inflation worries mount, Casey's General Stores, Johnson & Johnson, and PepsiCo stand out as defensive dividend payers with healthy balance sheets, growing payouts, and buyback programs. 
Via MarketBeat
Topics Economy
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
Is AbbVie the Best Dividend King to Buy in September? ↗
It is certainly a good Dividend King to buy in September. 
Via The Motley Fool
Topics Intellectual Property
News headline image
My Top 5 Favorite Stocks for an Uncertain Market ↗
These players offer a certain level of stability in any market environment. 
Via The Motley Fool
Topics Artificial Intelligence Economy Intellectual Property
Discover which dow jones stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
3 Healthcare Stocks for 3 Stages of Life ↗
Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends. 
Via MarketBeat
News headline image
Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition ↗
Johnson & Johnson (NYSE:JNJ) executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline... 
Via MarketBeat
Topics ETFs Economy
News headline image
2 Outstanding Dividend Stocks to Buy and Hold for 10 Years ↗
Income seekers can't go wrong with these companies. 
Via The Motley Fool
Topics Intellectual Property
Friday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
These dow jones stocks are moving in today's session ↗
Via Chartmill
News headline image
These 5 ETFs Are Built for Bear Markets. History Says Now Is a Fantastic Time to Buy. ↗
During bear markets and recessions, it's good to be invested in "defensive" stocks and funds that hold up better than average. 
Via The Motley Fool
Topics ETFs Economy
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.